These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8801590)

  • 21. Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Nov; 847(1):139-42. PubMed ID: 10564747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of electrophysiological method to study interactions between ibogaine and cocaine.
    Binienda Z; Beaudoin MA; Thorn BT; Sadovova N; Skinner RD; Slikker W; Ali SF
    Ann N Y Acad Sci; 2000 Sep; 914():387-93. PubMed ID: 11085337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission.
    Collins SL; D'Addario C; Izenwasser S
    Eur J Pharmacol; 2001 Aug; 426(1-2):25-34. PubMed ID: 11525767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity.
    Collins SL; Gerdes RM; D'Addario C; Izenwasser S
    Behav Pharmacol; 2001 Jul; 12(4):237-45. PubMed ID: 11548109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of antiaddictive actions of ibogaine.
    Glick SD; Maisonneuve IS
    Ann N Y Acad Sci; 1998 May; 844():214-26. PubMed ID: 9668680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
    Wells GB; Lopez MC; Tanaka JC
    Brain Res Bull; 1999 Apr; 48(6):641-7. PubMed ID: 10386845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaine.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Pharmacol Biochem Behav; 1999 Jul; 63(3):457-64. PubMed ID: 10418788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2000 Jun; 398(2):259-62. PubMed ID: 10854838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine.
    Chefer VI; Morón JA; Hope B; Rea W; Shippenberg TS
    Neuroscience; 2000; 101(3):619-27. PubMed ID: 11113311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo electrochemical studies of gradient effects of (SC) cocaine on dopamine and serotonin release in dorsal striatum of conscious rats.
    Broderick PA
    Pharmacol Biochem Behav; 1993 Dec; 46(4):973-84. PubMed ID: 8309978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of Antiaddictive Actions of Ibogaine
    Glick SD; Maisonneuve IM
    Ann N Y Acad Sci; 1998 May; 844(1):214-226. PubMed ID: 29090809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
    Cao YJ; Bhargava HN
    Brain Res; 1997 Mar; 752(1-2):250-4. PubMed ID: 9106464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of serotonin in the regulation of the dynorphinergic system by a kappa-opioid agonist and cocaine treatment in rat CNS.
    D'Addario C; Di Benedetto M; Izenwasser S; Candeletti S; Romualdi P
    Neuroscience; 2007 Jan; 144(1):157-64. PubMed ID: 17055175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
    Glick SD; Maisonneuve IM; Szumlinski KK
    Ann N Y Acad Sci; 2000 Sep; 914():369-86. PubMed ID: 11085336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Feb; 818(1):96-104. PubMed ID: 9914442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.
    Maisonneuve IM; Rossman KL; Keller RW; Glick SD
    Brain Res; 1992 Mar; 575(1):69-73. PubMed ID: 1504783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats.
    Szumlinski KK; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 1999 Jul; 145(2):227-33. PubMed ID: 10463325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes.
    Efange SM; Mash DC; Khare AB; Ouyang Q
    J Med Chem; 1998 Nov; 41(23):4486-91. PubMed ID: 9804688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.